Search by Drug Name or NDC

    NDC 00054-0576-28 Deferiprone 500 mg/1 Details

    Deferiprone 500 mg/1

    Deferiprone is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is DEFERIPRONE.

    Product Information

    NDC 00054-0576
    Product ID 0054-0576_f52c4949-6261-46d0-beda-5ceb8ce227a9
    Associated GPIs 93100028000320
    GCN Sequence Number 046924
    GCN Sequence Number Description deferiprone TABLET 500 MG ORAL
    HIC3 C8A
    HIC3 Description METALLIC POISON,AGENTS TO TREAT
    GCN 84849
    HICL Sequence Number 018544
    HICL Sequence Number Description DEFERIPRONE
    Brand/Generic Generic
    Proprietary Name Deferiprone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Deferiprone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name DEFERIPRONE
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Iron Chelating Activity [MoA], Iron Chelator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213239
    Listing Certified Through 2024-12-31

    Package

    NDC 00054-0576-28 (00054057628)

    NDC Package Code 0054-0576-28
    Billing NDC 00054057628
    Package 300 TABLET, COATED in 1 BOTTLE (0054-0576-28)
    Marketing Start Date 2021-06-03
    NDC Exclude Flag N
    Pricing Information N/A